View in EDS

Combination Therapy, Drug Interactions, and Survival Outcomes in Metastatic Breast Cancer: A Pooled Analysis of Phase II Trials.

Saved in:
Bibliographic Details
Title: Combination Therapy, Drug Interactions, and Survival Outcomes in Metastatic Breast Cancer: A Pooled Analysis of Phase II Trials.
Authors: Azam F; School of Pharmacy, BRAC University, Dhaka, Bangladesh.; Evidence Based Medicine Research Group, School of Pharmacy, BRAC University, Dhaka, Bangladesh., Momtaz T; School of Pharmacy, BRAC University, Dhaka, Bangladesh.; Evidence Based Medicine Research Group, School of Pharmacy, BRAC University, Dhaka, Bangladesh., Islam F; School of Pharmacy, BRAC University, Dhaka, Bangladesh.; Evidence Based Medicine Research Group, School of Pharmacy, BRAC University, Dhaka, Bangladesh., Rahman KF; School of Pharmacy, BRAC University, Dhaka, Bangladesh.; Evidence Based Medicine Research Group, School of Pharmacy, BRAC University, Dhaka, Bangladesh., Shobnam S; School of Pharmacy, BRAC University, Dhaka, Bangladesh., Paul P; School of Pharmacy, BRAC University, Dhaka, Bangladesh., Alam MJ; School of Pharmacy, BRAC University, Dhaka, Bangladesh.
Source: Clinical Medicine Insights. Oncology [Clin Med Insights Oncol] 2026 Jul 25; Vol. 20, pp. 11795549261473457. Date of Electronic Publication: 2026 Jul 25 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 101525771 Publication Model: eCollection Cited Medium: Print ISSN: 1179-5549 (Print) Linking ISSN: 11795549 NLM ISO Abbreviation: Clin Med Insights Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42504296
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combination Therapy, Drug Interactions, and Survival Outcomes in Metastatic Breast Cancer: A Pooled Analysis of Phase II Trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Azam+F%22">Azam F</searchLink>; School of Pharmacy, BRAC University, Dhaka, Bangladesh.; Evidence Based Medicine Research Group, School of Pharmacy, BRAC University, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Momtaz+T%22">Momtaz T</searchLink>; School of Pharmacy, BRAC University, Dhaka, Bangladesh.; Evidence Based Medicine Research Group, School of Pharmacy, BRAC University, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Islam+F%22">Islam F</searchLink>; School of Pharmacy, BRAC University, Dhaka, Bangladesh.; Evidence Based Medicine Research Group, School of Pharmacy, BRAC University, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Rahman+KF%22">Rahman KF</searchLink>; School of Pharmacy, BRAC University, Dhaka, Bangladesh.; Evidence Based Medicine Research Group, School of Pharmacy, BRAC University, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Shobnam+S%22">Shobnam S</searchLink>; School of Pharmacy, BRAC University, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Paul+P%22">Paul P</searchLink>; School of Pharmacy, BRAC University, Dhaka, Bangladesh.<br /><searchLink fieldCode="AU" term="%22Alam+MJ%22">Alam MJ</searchLink>; School of Pharmacy, BRAC University, Dhaka, Bangladesh.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101525771%22">Clinical Medicine Insights. Oncology</searchLink> [Clin Med Insights Oncol] 2026 Jul 25; Vol. 20, pp. 11795549261473457. <i>Date of Electronic Publication: </i>2026 Jul 25 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101525771 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1179-5549 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211795549%22">11795549 </searchLink><i>NLM ISO Abbreviation: </i>Clin Med Insights Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42504296
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/11795549261473457
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 11795549261473457
    Titles:
      – TitleFull: Combination Therapy, Drug Interactions, and Survival Outcomes in Metastatic Breast Cancer: A Pooled Analysis of Phase II Trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Azam F
      – PersonEntity:
          Name:
            NameFull: Momtaz T
      – PersonEntity:
          Name:
            NameFull: Islam F
      – PersonEntity:
          Name:
            NameFull: Rahman KF
      – PersonEntity:
          Name:
            NameFull: Shobnam S
      – PersonEntity:
          Name:
            NameFull: Paul P
      – PersonEntity:
          Name:
            NameFull: Alam MJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 07
              Text: 2026 Jul 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1179-5549
          Numbering:
            – Type: volume
              Value: 20
          Titles:
            – TitleFull: Clinical Medicine Insights. Oncology
              Type: main
ResultId 1